glp-1/gip agonists New strategies for the treatment of obesity and metabolic dysfunctions Dual and Triple Gut Peptide

Combination Therapies : The integration of GLP-1 agonists with other weight loss agents is under exploration, aiming to create synergies that offer superior weight loss outcomes

6 BiesselsG

Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes

However, for people with significant metabolic dysfunction like type 2 diabetes, the enhanced metabolic benefits might matter

8 weeks) significantly improves elevated blood urine nitrogen, serum creatinine, and urinary albumin excretion rate and alleviates renal hypertrophy, mesangial expansion and glomerular fibrosis in streptozocin-induced type 1 diabetic rat

The systems that matter most for dementia prevention In longevity medicine, the practical question is not whether one therapy is good for the brain. The better question is whether the persons overall biology is moving toward resilience or vulnerability